We analyzed the expression profile of the individual inflammatory cell types, and our results are in accordance with other studies indicating that tumor-infiltrating lymphocytes correlate with hormone receptor-negative or HER2+ status, or with high grade/highly proliferative tumors, although we did not find correlation with favorable long-term prognosis [12]–[19]. The gene discussed is ERBB2; the disease is neoplasm.